Autopsy report · NCT06638749

Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty

“Administrative withdrawal-study not approved by IRB”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

University of Kansas Medical Center

Sponsor type

University, hospital or other

Conditions

Shoulder Arthritis; Blood Loss, Surgical; Tranexamic Acid Adverse Reaction

Interventions

Tranexamic Acid; Normal Saline

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study
  “Study never initiated; withdrawn prior to receiving IRB approval” (89% match in meaning)
• Antibiotics and Tissue Expanders in Breast Reconstruction
  “The study was withdrawn prior to IRB approval.” (83% match in meaning)
• Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue
  “Withdrawn-was not approved by IRB” (82% match in meaning)
• A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes
  “Study withdrawn from IRB approval process by PI” (82% match in meaning)
• Suprainguinal Fascia Iliaca Compartment Block in Direct Anterior Approach to Total Hip Arthroplasty
  “Study never approved by IRB or initiated” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.